In his new role leading the Chan Zuckerberg Biohub New York, Andrea Califano will bring together scientists from several universities to engineer the immune system to detect and treat disease.
In the GUARDIAN study, the genomes of newborns are being scanned to identify children who have one of hundreds of treatable and preventable rare genetic conditions before symptoms emerge.
CUMC scientists have created a 3-D printed implant that stimulates stem cells to regenerate the meniscus, cartilage that cushions and protects the knee.
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
For a year, diabetes patient Doug Kanter tracked every blood sugar reading, every insulin dose, every meal, and all of his activity to produce the quintessential selfie.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.